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Abstract
Cell growth and division are required for the progression of bacterial infections. Most rod-
shaped bacteria grow by inserting new cell wall along their mid-section. However, mycobac-
teria, including the human pathogenMycobacterium tuberculosis, produce new cell wall
material at their poles. How mycobacteria control this different mode of growth is incom-
pletely understood. Here we find that PonA1, a penicillin binding protein (PBP) capable of
transglycosylation and transpeptidation of cell wall peptidoglycan (PG), is a major governor
of polar growth in mycobacteria. PonA1 is required for growth ofMycobacterium smegmatis
and is critical forM. tuberculosis during infection. In both cases, PonA1’s catalytic activities
are both required for normal cell length, though loss of transglycosylase activity has a more
pronounced effect than transpeptidation. Mutations that alter the amount or the activity of
PonA1 result in abnormal formation of cell poles and changes in cell length. Moreover,
altered PonA1 activity results in dramatic differences in antibiotic susceptibility, suggesting
that a balance between the two enzymatic activities of PonA1 is critical for survival. We also
find that phosphorylation of a cytoplasmic region of PonA1 is required for normal activity.
Mutations in a critical phosphorylated residue affect transglycosylase activity and result in
abnormal rates of cell elongation. Together, our data indicate that PonA1 is a central deter-
minant of polar growth in mycobacteria, and its governance of cell elongation is required for
robust cell fitness during both host-induced and antibiotic stress.
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Author Summary
Bacterial infections rely on continued bacterial growth. Studying cell growth is particularly
important for pathogens such asMycobacterium tuberculosis that grow differently than
model organisms. Unlike Escherichia coli or Bacillus subtilis, which grow by incorporating
cell wall material along their body, mycobacteria grow from the pole. It remains unclear
how mycobacteria construct and extend their poles. Our work identifies a cell wall
synthase, PonA1, as a key determinant of mycobacterial polar growth. PonA1 governs
polar growth through two enzymatic activities that build the cell wall’s peptidoglycan
(PG); both of these activities are required for normal cell growth. Changes in the amount
or activity of PonA1 leads to misplaced cell poles and inhibition of cell proliferation.
PonA1 is phosphorylated, an unusual modification for PG synthases. This phosphoryla-
tion tunes the rate of cell elongation. Changing PonA1’s regulatory or enzymatic activity
impacts the survival of cells in the host or when treated with antibiotics. Our work shows
how mycobacterial cell pole construction and cell fitness is governed by a major cell wall
synthase; these findings may have implications for other bacteria that elongate from their
poles.
Introduction
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), remains a significant
threat to human health. The World Health Organization estimates that 1.5 million individuals
die of TB every year, and that roughly 2 billion people are latently infected withM. tuberculosis
(Mtb)[1]. Despite the substantial global burden of TB, little is known about the bacterium’s
basic physiological pathways, including cell growth and division.
Two processes govern growth of rod-shaped bacterial cells: elongation of the cell and then
division of that cell into two daughter cells. This growth and division requires extensive remod-
eling of the cell wall, a layer or layers of complex saccharides that surrounds the cell’s plasma
membrane. Cell division involves the synthesis and then splitting at mid-cell of a peptidoglycan
layer (a macromolecule composed of disaccharides crosslinked by short peptides), called the
septum. Bacteria elongate by incorporating new cell wall material into their existing cell wall.
Many rod-shaped bacteria grow by elongating their mid-section; however, mycobacteria have a
different body plan and elongate by incorporating new cell wall precursors at the cell poles
[2,3].
Cell growth and division rely on the synthesis of new cell wall. The bacterial cell wall is
required for cell survival and determines bacterial shape. Peptidoglycan (PG) is a major com-
ponent of bacterial envelopes and is central to the integrity of the cell wall. PG is remodeled in
response to stress and undergoes rounds of synthesis and hydrolysis every cell cycle to promote
cell elongation and division[2,3]. Although coordination of PG synthesis has been extensively
studied in other bacterial species, this process, particularly during elongation, remains rela-
tively unexplored in mycobacteria.
One key enzyme that plays a central role in elongation and septation is PonA1, which local-
izes to the cell pole and septum, where it interacts with the essential PG hydrolase RipA[4,5].
Our previous work suggested that PonA1 was essential inMycobacterium smegmatis (Msm)
[4], indicating that we could useMsm as a convenient tool to define cellular activity specific to
PonA1. Studying PonA1 enables us to determine how the cell governs one of the most critical
steps in PG synthesis—elongation of the cell pole.
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PonA1 is a penicillin binding protein (PBP), a member of a family of proteins that promotes
cell growth and division through the synthesis of PG[2,3]. PonA1 has two extracellular catalytic
domains that carry out the two necessary reactions for peptidoglycan synthesis: transglycosyla-
tion (TG) and transpeptidation (TP). TG reactions link the repeating disaccharide units that
form the glycan backbone of peptidoglycan. Pentapeptide tails descend from the glycan chains
and are crosslinked by TP reactions[2,3]. In addition to its two catalytic domains, PonA1 con-
tains a long unconserved cytoplasmic tail. The cytoplasmic tail is phosphorylated[6], an
unusual modification for PBPs that may play a role in PonA1’s cellular function.
Here we provide evidence that PonA1 is required for cell proliferation inMsm and is neces-
sary for normal survival ofMtb during infection. It plays multiple roles in determining cell
length and defining new growth. PonA1 is an early polar localizing factor that can nucleate
elongation complexes to construct new cell poles, whose elongation rates are modulated by
PonA1’s phosphorylation. Changes in PonA1 activity impact cell shape and growth, likely
through insults to the cell wall peptidoglycan, which ultimately results in reduced cell fitness
during infection and stress. Collectively, our data suggest that cell elongation in mycobacteria
requires PonA1, whose catalytic and regulatory activities modulate the function of cell growth
complexes.
Results
Normal growth ofM. smegmatis andM. tuberculosis requires PonA1
Transcriptional depletion of ponA1 (MSMEG_6900, Entrez Gene ID 4536904) was previously
shown to severely impact proliferation ofMsm and induces the formation of lemon-shaped or
ballooning cells, suggesting that PonA1 plays a critical role in cell growth in mycobacteria[4].
To determine whether PonA1 is essential for growth ofMsm, we used an allelic replacement
system[7] that allows exchange of PonA1 alleles on the bacterial chromosome (Fig 1A). We
generated two exchange vectors, one encoding wildtype ponA1 and a negative control vector
lacking ponA1. Exchanging wildtype ponA1 with a similar wildtype ponA1 fully restored bacte-
rial growth; however, exchange of ponA1 with the negative control vector abolished bacterial
growth (Fig 1A). The few remaining colonies on the negative control plate were confirmed
ponA1+ by PCR (seven colonies from approximately 4x108 transformed cells). These data show
that growth ofMsm requires ponA1. However, transposon mutagenesis data fromM. tubercu-
losisH37Rv (Mtb) suggested that ponA1 (Rv0050, Entrez Gene ID 887065) could be disrupted
without compromising proliferation ofMtb in culture[8], but that such a disruption would
impact survival in a mouse model of TB[9]. We therefore tested whether ponA1 could be
deleted from theMtb genome by recombineering (see Materials and Methods for details). We
successfully isolated a ΔponA1 Mtbmutant and confirmed that ΔponA1 Mtb cells grew simi-
larly to wildtypeMtb under standard laboratory culture conditions (S1A and S1B Fig). How-
ever, ΔponA1 Mtb cells replicated less robustly than wildtypeMtb in the lungs of C57Bl6 mice
at 15 and 42 days post infection (dpi) and were moderately impaired in dissemination to the
spleen at 42 dpi (Fig 1B), indicating that loss of PonA1 impactedMtb fitness during infection.
Together, these data show that PonA1 is necessary for normal growth ofMsm in culture and
promotes normal fitness ofMtb during infection.
PonA1’s synthesis of glycan chains is essential forM. smegmatis
viability and for normal cell length ofM. tuberculosis
PonA1’s essentiality inMsm is unusual, since bifunctional PBPs in many bacterial species,
including Escherichia coli[10], Bacillus subtilis[11], Vibrio cholerae[12], and even the closely
PonA1 Governs Mycobacterial Polar Growth
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Fig 1. PonA1 is essential inM. smegmatis and required for normal growth ofM. tuberculosis. (A) An allelic exchange system inM. smegmatis
provides an efficient method to test the importance of PonA1 for bacterial survival. PonA1 is essential inM. smegmatis, as allelic exchange with a vector
encoding ponA1 complements bacterial growth, while allelic exchange with a negative control vector fails to rescue growth. (B) C57Bl6 mice were aerosol
infected with H37Rv wildtype, ΔponA1, ΔponA1::ponA1wt, and ΔponA1::ponA1TG- (an allele of PonA1 with a catalytic active site mutation in the
transglycosylase (TG) domain), and CFU were enumerated were from lung and spleen homogenates at 15 and 42 days post infection (dpi). ΔponA1 and
ΔponA1::ponA1TG- cells are less fit than H37Rv wildtype or isogenic wildtype, respectively, at 15 and 42 dpi. Statistical significance was calculated by a one-
tailed t-test (lungs at 15 dpi, H37Rv compared to ΔponA1 *** indicates p-value = 0.0005; lungs 42 dpi, H37Rv compared to ΔponA1 ** indicates p-
value = 0.0089, and ΔponA1::ponA1wt compared to ΔponA1::ponA1TG- ** indicates p-value = 0.0042. Spleens at 42 dpi, H37Rv compared to ΔponA1 ***
indicates p-value = 0.0001, and ΔponA1::ponA1wt compared to ΔponA1::ponA1TG- * indicates p-value = 0.0122). PonA1, while not required for growth ofM.
tuberculosis in culture, is required for normal bacterial multiplication and dissemination during infection in a mouse model of tuberculosis.
doi:10.1371/journal.ppat.1005010.g001
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related, polar growing actinomycete Corynebacterium glutamicum[13] have largely redundant
roles. TheMsm genome encodes two other bifunctional PBPs, PonA2 and PonA3, with pre-
sumably similar catalytic activities[14], whereasMtb encodes just PonA1 and PonA2[15]. To
identify which function of PonA1 was essential inMsm, we produced a panel of PonA1
mutants with varying catalytic functionality (S2A Fig) for use in the allelic exchange system
shown in Fig 1A. Mutations in homologous active site residues eliminated catalytic activity in
in vitro assays for E. coli PBP1a[16] and PBP1b[17]. In E. coli, genetic ablation of TP activity
did not alter TG activity[16,17], whereas elimination of TG activity also abolished the enzyme’s
TP activity in vitro, presumably because the substrate for the TP reaction was not produced
[16,17]. However, whether loss of TP activity also abolishes TG activity in the cell remains
unclear.
To test whether TG, TP or both activities were required to sustain growth, we transformed
Msm with the exchange vectors and tested for appropriate chromosomal integration by antibi-
otic selection (see Materials and Methods). We found that only a PonA1TP- allele (predicted to
lack TP activity) was capable of rescuing bacterial growth while PonA1TG- and PonA1TG-TP-
alleles (which lack either TG or both activities) failed to rescue bacterial survival (Fig 2A).
These data suggest that PonA1’s polymerization of glycan strands is required inMsm, but that
its crosslinking of PG is dispensable. This is consistent with a previous report of anMsm
mutant with a transposon insertion in ponA1 that generates a truncated protein that includes
the TG domain but lacks the TP domain[18]. This mutant is likely still capable of transglycosy-
lation but lost the ability to catalyze transpeptidation [18].
InMtb, PonA1’s synthesis of glycan chains is required for normal bacterial growth.Mtb
cells that expressed a PonA1TG- allele exhibited moderately impaired viability and dissemina-
tion during infection, similar to ΔponA1 cells, when compared to isogenic wildtype (Fig 1B).
This fitness defect could be associated with abnormal cell length, as ΔponA1 and ΔponA1 L5::
ponA1TG- cells are shorter than their isogenic wildtypes by 14% and 21%, respectively (Fig 2B)
but showed no gross cell shape changes or substantial population doubling defects (S1A, S1B
and S1C Fig). The ΔponA1 L5::ponA1TG- cells also produced somewhat less phthiocerol dimy-
cocerosate (PDIM) (S3 Fig), a cell wall lipid that is important for robust growth during infec-
tion. Lower PDIM production by this strain may contribute to the decreased fitness of these
cells in the host, although we do not suspect that low PDIM is related to TG- PonA1 as low
PDIM production has been described in unrelated genetic mutants[19]. Furthermore, ΔponA1
Mtb cells exhibit a cell length defect but produce PDIM at levels similar to or slightly above
wildtype H37Rv, suggesting that PDIM loss is not correlated with decreased cell length. The
change in cell length observed with ΔponA1 and ΔponA1 L5::ponA1TG- cells suggests that
PonA1’s polymerization of glycan chains is required for normal cell length inMtb. Altered
peptidoglycan structure in these shorter cells likely underlies their decreased ability to resist
host-induced stresses.
Correct cell length depends on PonA1’s crosslinking of peptidoglycan
The differential essentiality of PonA1’s TG and TP activities in the cell suggested that they
could be uncoupled. Uncoupling of the TG and TP activities for PonA1 may be unusual. in
vitro studies have shown that in other bifunctional PBPs, the TP domain crosslinks the nascent
glycan strands produced by the cis-TG domain, and it cannot function in the absence of TG
activity[16,17,20]. To determine whether PonA1’s crosslinking activity depended on its ability
to polymerize glycan strands, we tested whether the PonA1TG- allele could bind to a fluorescent
penicillin analog, bocillin-FL, which covalently interacts with the transpeptidase domain active
site serine[21]. Using FLAG-tagged PonA1 isoforms, we found that PonA1TG- binds to bocillin
PonA1 Governs Mycobacterial Polar Growth
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Fig 2. PonA1’s glycan synthesis is required inM. smegmatis and catalytic activity promotes normal cell elongation. (A) Allelic exchange (see Fig
1A) with vectors encoding alleles of PonA1 with varying catalytic activities (TG-, transglycosylase mutant; TP-, transpeptidase mutant; TG-TP-,
transglycosylase and transpeptidase double mutant) demonstrates that a TG- allele fails to rescue bacterial survival. In contrast, a TP- allele complements
bacterial growth. It is likely that PonA1’s synthesis of the glycan backbone of peptidoglycan is required for cell survival while other enzymes coordinate with
PonA1 to crosslink those glycan strands into the existing sacculus. (B)M. tuberculosis strains were grown in culture and total cell length was measured:
PonA1 Governs Mycobacterial Polar Growth
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at a level similar to wildtype PonA1, whereas PonA1TP- and PonA1TG-TP- did not bind to bocil-
lin, as expected (Fig 2C). FLAG immunoblotting confirmed the bocillin-labeled band was
PonA1-FLAG (S2B Fig). These data suggest that PonA1’s catalytic activities can be uncoupled,
and specifically that its transpeptidase activity does not require active cis-transglycosylation.
Accordingly, we hypothesized that the uncoupling of PonA1’s catalytic activities could
impact cell elongation and/or division, resulting in altered cell morphology. We imagedMsm
cells that expressed PonA1wt or PonA1TP- and quantified cell length. We found that PonA1TP-
Msm were 24% shorter on average than isogenic wildtype (Fig 2D and 2E) and had impaired
population doubling (S2C and S2D Fig) although similar levels of protein were expressed (S2E
Fig). These data suggest that PonA1’s crosslinking of PG is required for normal cell length, and
that the balance of PonA1 catalytic activities could have a role in controlling cell length and
withstanding stress. Impaired PonA1 crosslinking inMtb decreased cell length as well. Cells
that expressed a PonA1TP- or PonA1TG-TP- allele were 11% or 6% shorter on average, respec-
tively, than isogenic wildtype (Fig 2B). These data indicate that while PonA1’s TG activity is
critical for cell viability and normal cell length (Figs 1B and 2), its TP activity also has a role in
maintaining correct cell length inMtb, although these mutations do not significantly alter pop-
ulation doubling rates (S1B, S1C and S1D Fig).
PonA1’s transpeptidase domain is dispensable for cell survival
As PonA1’s TG activity is necessary for the viability ofMsm, we hypothesized that the TG
domain as the sole periplasmic domain would be sufficient to rescue bacterial growth. Further-
more, our previous work indicated that PonA1 dampened the hydrolytic activity of the
RipA-RpfB complex in vitro[4], suggesting that PonA1’s modulation of RipA’s lytic activity
could also contribute to the requirement of PonA1 inMsm. PonA1’s TP domain mediates the
interaction with RipA[4]. To test whetherMsm could survive with only PonA1’s TG domain in
the periplasm, we generated a truncation mutant of PonA1 that eliminated the TP domain
(PonA11-360) (S2A Fig). We tested whether this truncation could complement loss of PonA1
via allelic exchange (Fig 1A). We found that PonA11-360 could support bacterial survival and
growth. However, cells that expressed PonA11-360 exhibited cell shape defects (Fig 3A) and
were 38% shorter than isogenic wildtype cells (Fig 3B). These morphological changes translated
to diminished population growth rates (S2F and S2G Fig); however, these phenotypic differ-
ences were not due to difference in protein expression of the truncated PonA1 allele (S2H Fig).
In sum, these data suggest that PonA1’s TG activity is necessary and that the TG domain is the
critical periplasmic domain required for the survival ofMsm. PonA1 modulation of RipA activ-
ity may be an important cellular role for PonA1, but it is not absolutely required for viability of
Msm, which has other means of controlling RipA lytic activity[5].
H37Rv wildtype (234 cells), ΔponA1 (241 cells; approximate p-value < 0.0001 by the Kolmogorov-Smirnov test), ΔponA1 L5::ponA1wt (212 cells), ΔponA1
L5::ponA1TG- (220 cells; approximate p-value < 0.0001 by the Kolmogorov-Smirnov test), ΔponA1 L5::ponA1TP- (227 cells; approximate p-value < 0.0001 by
the Kolmogorov-Smirnov test), and ΔponA1 L5::ponA1TG-TP- (209 cells; approximate p-value < 0.0001 by the Kolmogorov-Smirnov test). Loss of PonA1 or
expression of a TG- allele of PonA1 reduces cell length compared to their isogenic wildtypes, supporting the role of PonA1’s TG activity in regulating cell
growth inM. tuberculosis. Loss of TP activity had a more modest effect on cell length. (C)Msm PonA1 isoforms were produced in E. coli and assessed for
their ability to bind bocillin-FL. Lane 1, negative control (wildtype E. coli); lane 2, PonA1wt; lane 3, PonA1TP-; lane 4, PonA1TG-; lane 5, PonA1TG-TP-. Mutants
that lack TP activity cannot bind bocillin-FL. However, PonA1TG- binds bocillin-FL at a level similar to wildtype PonA1, showing that PonA1’s catalytic
activities can be uncoupled. (D)Msm cells that express PonA1TP- do not exhibit gross cell shape changes, suggesting another enzyme coordinates
peptidoglycan crosslinking with PonA1 to maintain cell integrity. Scale bar, 2 μm. (E) ΔponA1 L5::ponA1TP- cells (229 cells) are shorter than wildtypeM.
smegmatis (wt Msm, 251 cells; approximate p-value < 0.0001 by the Kolmogorov-Smirnov test) or isogenic wildtype (ΔponA1 L5::ponA1wt, 247 cells;
approximate p-value < 0.0001 by the Kolmogorov-Smirnov test), indicating that PonA1’s crosslinking influences cell length.
doi:10.1371/journal.ppat.1005010.g002
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Linear polar elongation requires balanced PonA1 activity
Our data together suggest that PonA1 is critical for robust growth and that its catalytic activity
is required for normal cell length. Do these critical catalytic activities lead to a dominant nega-
tive phenotype such that replacing wildtype PonA1 in cell growth complexes induces cellular
toxicity? We tested this hypothesis by overproducing PonA1 inMsm. The overproduction of
the PonA1TG-TP- double mutant induced the formation of ectopic cell poles (Fig 4A) and
severely inhibited population growth rates (Fig 4B), as did the single catalytic mutants. How-
ever, we observed the same phenotypes with overproduction of wildtype PonA1 (Fig 4A and
4B). This is in contrast to overproduction of the PonA1 homologue PBP1b in E. coli, which
exhibits a dominant negative phenotype when overexpressed; namely, catalytically inactive
PBP1b, but not wildtype PBP1b, inhibited growth and induced cell lysis[22]. These data suggest
the cellular activity of PonA1 is different than its PBP1b homologue in E. coli. The growth inhi-
bition with PonA1 overproduction inMsm correlated with the observation that the wildtype
ponA1 complement inMtb (ΔponA1 L5::PonA1wt), which is driven by a strong promoter, did
not fully complement wildtype growth at later time points in both lungs and spleens (Fig 1B).
These data suggest that overproduction of PonA1 inMtb also impacted cell fitness. Collec-
tively, these results indicate that the cell must tightly regulate PonA1 levels and activity to
maintain robust cell growth.
Fig 3. PonA1’s periplasmic domainsmodulate cell shape in mycobacteria. (A) Replacement of wildtype PonA1 with a PonA1 truncation containing the
cytoplasmic tail and TG domain (PonA11-360) rescues bacterial survival. Cells exhibit shape changes, but survive, suggesting that PonA1’s TG domain is the
sufficient periplasmic domain required for bacterial growth. Cell shape may change due to missing protein-protein interactions that occur along the TP
domain. Scale bar, 2 μm. (B) PonA11-360 cells (266 cells) are shorter than isogenic wildtype (251 cells; approximate p-value < 0.0001 by the Kolmogorov-
Smirnov test), which may indicate that the TP domain plays a role in complex formation that influences cell length. These measurements were taken on a
different day than Fig 2C and 2D, hence the slight difference in isogenic wildtype cell length.
doi:10.1371/journal.ppat.1005010.g003
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Although PonA1’s enzymatic activity is not required for ectopic pole formation inMsm, it
influenced the frequency of ectopic poles. Cells that overproduced PonA1TG- induced the for-
mation of multi-poled cells at a higher frequency than other alleles of PonA1 (Fig 4C). Taken
together, these results suggest that some balance between TG and TP activities is required to
induce pole formation. However, no enzymatic activity is required for this phenomenon,
Fig 4. Excess PonA1 induces ectopic polar growth inM. smegmatis. (A)Overexpression of PonA1 causes the formation of ectopic growth poles,
regardless of PonA1’s catalytic activity, suggesting that PonA1’s complex formation is sufficient to induce ectopic polar growth. Scale bar, 2 μm. (B) Excess
levels of PonA1, including wildtype PonA1, inhibit bacterial multiplication, likely because of ectopic polar growth. (C) Although PonA1’s catalytic activity is not
required for ectopic pole formation, it does influence the frequency at which ectopic poles form. Cells that express a TG- allele form ectopic poles at more
than 2 times the frequency of other PonA1 alleles, suggesting that local peptidoglycan architecture could influence ectopic pole formation (statistical
significance was assessed by one-way analysis of variance with Bonferroni’s multiple comparison test, and multiplicity adjusted p-values are reported.
PonA1wt compared to PonA1TG-, p-value = 0.0039; PonA1TG- compared to PonA1TP-, p-value = 0.0225; PonA1TG- compared to PonA1TG-TP-, p-
value = 0.0042). (D) PonA1-RFP localizes to both growing tips of the ectopic pole, indicating that PonA1 is involved in nucleating elongation complexes at
these growth tips.
doi:10.1371/journal.ppat.1005010.g004
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suggesting another role for PonA1, perhaps as a scaffold or recruitment factor within protein
complexes that promote cell pole growth.
Previous work showed that ectopically-produced PonA1-RFP localized to the pole and sep-
tum[4]. A chromosomally RFP-tagged ponA1 also exhibits polar and mid-cell localization
(S3D Fig). To determine whether PonA1 localized at the ectopic growth pole, we imagedMsm
cells that overproduced PonA1-RFP. We observed that PonA1-RFP localized to each ectopic
tip of the growing pole (Fig 4D). Furthermore, PonA1 localized to the pole prior to its degener-
ation into ectopic poles (S5A Fig, follow pole with white arrow, and S1 Video), suggesting that
PonA1 is an early localizing factor that promotes elongation of the cell pole. Ectopic polar
growth occurred predominantly from one pole and not both poles (Figs 4A, S4 and S5), which
correlates with the expected pattern of asymmetric polar elongation[23,24], and cells that did
not overexpress PonA1 did not exhibit ectopic polar growth (Figs 4A, S5B and S2 Video).
Occasional cells with bulges or ectopic poles exhibited no RFP signal at those foci. PonA1’s
localization to the pole prior to the generation of ectopic poles indicates that PonA1 is inti-
mately involved in not just elongating the pole, but in formation of the cell pole itself, poten-
tially through interaction with DivIVA, which is required for pole formation in mycobacteria
[24]. Furthermore, overexpression of PonA1 did not induce misplaced septa, suggesting that
the majority of PonA1 is targeted to the cell pole during normal growth.
Ectopic polar growth upon overproduction of PonA1 inMsm is distinct from that observed
in E. coli, where ectopic branches appeared when combinations of PBP1a and several low
molecular weight PBPs were jointly deleted[25,26]. These data suggest that PonA1’s role in
mycobacterial growth is distinct from the homologous bifunctional PBPs in E. coli. This pheno-
type may be due to the fundamentally different way that mycobacteria elongate—from the cell
pole and not along the lateral body as in E. coli.
Mycobacteria control cell elongation through post-translational
modification of PonA1
One method the cell may use to regulate PonA1 activity is through post-translational modifica-
tion. The cytoplasmic tail of PonA1 fromMtb was recently identified as a substrate for the ser-
ine-threonine protein kinase PknB[6]. Prisic et al suggested the H37Rv genome had a
misannotated start site for rv0050, which was corroborated by another report that identified an
alternative protein translation start site in the 5’ UTR of ponA1[27]. We have used a construct
beginning 426 nucleotides upstream of the annotated start site, which captures the phosphory-
lation site, reported translational start site, and yields a predicted transmembrane domain[28]
(S6A Fig), a necessary feature of all PBPs[29]. We accordingly aligned the mc2155 genome for
Msm PonA1; the start site was shifted 126 nucleotides upstream, which aligned well with -426
Mtb PonA1 (S6A and S6B Fig). Furthermore, the -426Mtb PonA1 complemented growth of
Msm lacking endogenous PonA1, which demonstrated that the -426Mtb PonA1 allele was
functional (S6A and S6B Fig). The -426Mtb PonA1 protein was also produced at equivalent
levels toMsm PonA1 (S6C Fig). To test whether -426Mtb PonA1 was phosphorylated, we
purified from E. coli theMtb PonA1 cytoplasmic domain tagged to MBP along with his-MBP-
tagged kinase domains of all the functional serine-threonine kinases ofMtb. Phospho-transfer
profiling of MBP-Mtb PonA1cyto with the kinases revealed that PknB efficiently phosphory-
lated -426Mtb PonA1 in vitro (Fig 5A). The specificity of the phosphorylation on MBP-Mtb
PonA1cyto’s T34 residue (S6B Fig) was verified by mass spectrometric analysis (S7D Fig).
Because PknB’s phosphorylation of other targets modulates key steps in cell growth and
division[2], we hypothesized that PonA1’s phosphorylation might play a role in regulating cell
elongation or division. We tested this hypothesis by constructing two different alleles ofMsm
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Fig 5. Phosphorylation regulates the rate of cell elongation. (A) Phospho-transfer profiling with the kinase domains of the major serine-threonine protein
kinases ofM. tuberculosis (Mtb Pkn) reveals that PknB efficiently phosphorylatesMtbMBP-PonA1cyto. (B)M. smegmatis cells that express a T50A allele of
ponA1 (134 cells; approximate p-value = 0.0145 by the Kolmogorov-Smirnov test) are longer than isogenic wildtype cells (219 cells), while cells that express
a T50D allele (139 cells; approximate p-value = 0.0082 by the Kolmogorov-Smirnov test) are shorter than isogenic wildtype, suggesting PonA1’s
phosphorylation regulates cell elongation or division. (C) Timelapse microscopy revealed that cells that expressed a T50A (127 cells; approximate p-
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PonA1, one in which phosphorylation is blocked by substitution of an alanine residue for the
targeted threonine (T50A) and another where an aspartate substitution might mimic the effects
of phosphorylation (T50D) and confirmed these isoforms were stable (S6C Fig). We swapped
these for the native allele and measuredMsm cell length. Cells that expressed the T50A allele
were longer than isogenic wildtype, whereas cells that expressed the T50D allele were shorter
than isogenic wildtype (Fig 5B). Because the observed changes in cell length did not alter gross
optical density measurements of these cell populations (S8A Fig), we used timelapse micros-
copy to measure single cell elongation and division events. Cells were labeled with a green fluo-
rescent amine-reactive dye that stains the cell surface and does not diffuse over time. This
allows the visualization of new cell growth (S8B Fig)[23,30]. After labeling, cells were imaged
in custom microfluidic devices, and cell elongation and cell division events were quantified
over time (S8B Fig; see Materials and Methods for details).Msm cells that expressed
PonA1T50A allele elongated 15% faster than isogenic wildtype (Fig 5C). This faster elongation
rate correlated with increased cell length at division (S8C Fig), and did not alter generation
time at the single cell level (S8D Fig). Timelapse microscopy analysis did not show substantial
growth differences between the PonA1T50D mutant and isogenic wildtype cells. Truncation of
the cytoplasmic tail of PonA1 (PonA1Δcyto), which generated a stable protein (S6C Fig), phe-
nocopied the increased elongation rate (Fig 5C), supporting the role of PonA1’s cytoplasmic
domain, and likely its phosphorylation, in downregulating cell elongation. Cells that expressed
PonA1T50A or PonA1Δcyto elongated predominantly from the old pole (S8E Fig) instead of the
new pole (S8F Fig), in agreement with the expected growth pattern for mycobacteria[23,24].
These data indicate that loss of PonA1’s phosphorylation does not alter the subcellular localiza-
tion of elongation complexes or PonA1’s localization in the elongation complex itself. Thus, it
appears that PonA1’s cytoplasmic domain is not required for localization of PonA1 in the elon-
gation complex or for PonA1’s function in that complex. However, PonA1’s cytoplasmic tail
could interact with cytoplasmic factors that are involved in modulating or are required for the
activity of the elongation complex. For example, it could mediate interaction with DivIVA, an
essential determinant of polar growth in mycobacteria [24].
PonA1’s phosphorylation plays a similar role inMtb. We measured the length of cells that
expressed a PonA1 T34A or T34D isoform. We found that the T34A mutant increased cell
length by 5% compared to isogenic wildtype, whileMtb that encoded the T34D allele were 11%
shorter than isogenic wildtype (Fig 5D). These data correlate with the observation inMsm. Fur-
thermore, expression of T34AMtb PonA1 inMsm increased cell length ofMsm while expres-
sion of T34DMtb PonA1 decreasedMsm cell length. Collectively, these data suggest that
PonA1’s phosphorylation reduces elongation in bothMtb andMsm and provides the cell with
a facile method to modulate cell length, an important response to certain stress conditions,
including in-host survival[31].
Because PonA1’s phosphorylation was not essential for protein function, but did modulate
cell elongation rate, we hypothesized that PonA1’s phosphorylation regulated its enzymatic
activity. To test this, we generated a double mutant in which the phosphorylation and
value = 0.0002 by the Kolmogorov-Smirnov test) allele elongated faster than isogenic wildtype cells (174 cells), which was phenocopied by a truncation of the
cytoplasmic tail (Δcyto; 202 cells; approximate p-value < 0.0001 by the Kolmogorov-Smirnov test). These data suggest that PonA1’s phosphorylation
negatively regulates cell elongation. (D) Similarly, phosphorylation status of PonA1 affects total cell length inM. tuberculosis. Cells that expressed a T34A
allele (211 cells; approximate p-value = 0.0066 by the Kolmogorov-Smirnov test) exhibited an average cell length 5% longer than isogenic wildtype (202
cells), and cells that expressed a T34D allele (207 cells; approximate p-value < 0.0001 by the Kolmogorov-Smirnov test) were 11% shorter than isogenic
wildtype. This suggests that PonA1’s unusual phosphorylation negatively regulates cell elongation inM. tuberculosis as inM. smegmatis. (E)Msm cells that
encode a T50A,TP- allele of PonA1 are defective for normal cell separation. These cells form short chains of cells with multiple septa (white arrows). These
data suggest that PonA1’s phosphorylation may regulate PonA1 TG activity, the remaining functional catalytic activity for this allele, and that alterations to
PonA1’s TG activity impact the cell’s peptidoglycan and consequent cleavage of that peptidoglycan.
doi:10.1371/journal.ppat.1005010.g005
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transpeptidase active sites were ablated.Msm cells that expressed this double PonA1 mutant
(PonA1T50A,TP-) were defective for normal cell separation. Cells formed short chains with cells
of mixed length containing several septa (Fig 5E). This is distinct from the short cell phenotype
of TP- cells (Fig 2C and 2D) and the elongated cell phenotype of T50A cells (Fig 5B), neither
of which form short chains. Additionally, theMsm PonA1T50A,TP- cells had diminished
growth rates compared to either of the single mutants or isogenic wildtype (S9A and S9B Fig),
although similar protein levels were produced (S9C Fig). These data suggest that the peptido-
glycan synthesized by this PonA1 mutant diminishes efficient cleavage. This could indicate
that PonA1’s phosphorylation regulates its TG activity—the remaining enzymatic activity in
this mutant—and that the observed division defects result from imbalanced synthesis of
peptidoglycan.
Altering PonA1 activity changes antibiotic susceptibility
Because changes to PonA1’s phosphorylation status or synthetic ability altered cell shape and
viability, we investigated whether these mutations would impact cell physiology under stress
conditions, particularly antibiotic treatment. We previously demonstrated that single nucleo-
tide polymorphisms in ponA1 identified in clinical isolates alterMtb’s fitness during rifampicin
treatment[32]. We tested if alteredMtb PonA1 enzymatic or regulatory activity would also
impact susceptibility to rifampicin. Indeed,Mtb cells that expressed PonA1TG- or PonA1T34D
were 5 and 4 fold more tolerant to rifampicin treatment than isogenic wildtype, respectively
(S10A Fig). In contrast, the inactivation of PonA1’s TP activity or blockade of phosphorylation
did not alter cell survival in the presence of rifampicin (S10A Fig). In sum, these data suggest
that altering PonA1 catalytic and regulatory activity changes cell fitness in the presence of the
clinically relevant antibiotic rifampicin, although the mechanism remains unclear.
We also hypothesized that changes in PonA1 activity would alter susceptibility to cell wall
stress, including antibiotics that target PG synthesis. Genetically ablatingMtb PonA1’s TP
activity or its phosphorylation site decreased by 8- or 4-fold, respectively, the minimum inhibi-
tory concentration (MIC) of teicoplanin, a glycopeptide that inhibits PG crosslinking[33]
(Fig 6). The increased sensitivity to teicoplanin suggests that imbalanced peptidoglycan synthe-
sis occurred in TP- as well as T34A cells, supporting a model in which phosphorylation may
regulate PonA1’s TG activity (the remaining catalytic activity of the TP- mutant). A shifted tei-
coplanin MIC was also observed inMsm where the TP- allele exhibits a 16-fold change in MIC
(Fig 6), although theMsm T50A allele did not phenocopy the shifted teicoplanin MIC observed
inMtb. However,Msm cells that expressed PonA1T50A alleles were more susceptible to a range
of meropenem concentrations (S10B Fig), supporting the idea that balanced PonA1 activity is
required for architecturally sound peptidoglycan to resist stress. We also tested whether inhib-
iting glycan synthesis would impact cellular fitness of PonA1 mutants, but observed minimal
efficacy of the small molecule inhibitor moenomycin A (S10C Fig).
Our data suggested that PonA1 activity modulated cell fitness in the presence of drugs. We
tested whether changes to PonA1 activity would alter cell fitness under other chemical stresses
that target the cell wall. Upon treatment with SDS,Msm cells that expressed PonA1TP- and
PonA1T50A exhibited a modest decrease in survival (S11A and S11B Fig). D-amino acids have
also been shown to modulate cell wall homeostasis[34], and we tested the fitness of PonA1TP-
cells in the presence of D-Met.Msm PonA1TP- cells grew less robustly and did not reach the
same optical density at stationary phase as compared to isogenic wildtype cells (S11C and
S11D Fig). Furthermore, PonA1TP- cells exhibited aberrant cell shape in deep stationary phase.
After four days of growth in culture,Msm PonA1TP- cells became wider and shorter compared
to isogenic wildtype (S11E Fig, white arrows). These data together indicate that normal PonA1
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catalytic and regulatory activity is required for the synthesis of structurally robust peptidogly-
can to ensure cellular survival in the face of multiple stresses.
Discussion
The paradigms of cell growth and division in rod-shaped bacteria are based on organisms that
grow fundamentally differently than mycobacteria. Consequently, our understanding of myco-
bacterial growth—and the cell’s ability to repress growth—remains elementary. We have
Fig 6. PonA1’s transpeptidase activity is required for normal teicoplanin tolerance in mycobacteria. (A)Minimum inhibitory concentration (MIC) of
teicoplanin for wildtype and different PonA1 mutantM. tuberculosis strains is tabulated. Fold change in MIC is calculated from wildtypeMtb (for ΔponA1) or
isogenic wildtype (for the TG-, TP-, TG-TP-, T34A, and T34D strains). Cells that express a PonA1 TP mutant or the T34A allele are more sensitive to
teicoplanin than isogenic wildtype. No change, no fold change in MIC from appropriate wildtype strain. (B) Teicoplanin MICs forM. smegmatismutant strains
are tabulated. Fold change is calculated from isogenic wildtype. Cells that express a PonA1 TP mutant are more sensitive to teicoplanin than isogenic
wildtype.
doi:10.1371/journal.ppat.1005010.g006
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addressed this knowledge gap by investigating how a key cell wall synthase, PonA1, promotes
and regulates cell growth in mycobacteria.
PonA1 is non-redundant during cell growth
We found that PonA1 is essential inMsm and required for normal proliferation in the lung as
well as dissemination outside of the lung during anMtb infection (Fig 1). These data suggest
that the major PBPs in mycobacteria do not have truly redundant functions. This is similar to
E. coli where distinct complexes employ PBP1a or PBP1b in E. coli[3], as well as recent work in
V. cholerae[12] and Listeria monocytogenes[35] that show PBP1a and PBP1b have specialized
biological roles during infection. Furthermore, this implies a revision of the classic understand-
ing of the PBPs as redundant factors. Imperfect redundancy during stress could be exploited to
identify unique physiological roles for the PBPs in a variety of bacterial species.
The differential essentiality of PonA1 inMsm andMtb for growth in culture is somewhat
surprising; it suggests a difference in expression or functionality of other PBPs, such as the
highly homologous protein PonA2, in these species. The role for bifunctional PBPs inMtb cell
elongation is probably jointly filled by PonA1 and PonA2, whereasMsm has evolved to solely
depend on PonA1. Even though PonA1 exhibits different essentiality inMtb andMsm, the role
of PonA1 is likely highly similar in the two species. We found thatMtb PonA1 complements
survival ofMsm depleted of endogenous PonA1 (S7 Fig), and the two proteins are 70% identi-
cal at the sequence level (S6 Fig). Furthermore, our data suggest that the physiological role of
PonA1 in bothMsm andMtb is very similar.
Governance of cell length and shape
Our data suggest that PonA1’s polymerization of glycan strands plays a key role in determining
cell length (Figs 2 and 7A). Indeed, overproduction of TG-inactive PonA1 inMsm yields cells
38% shorter when compared to isogenic wildtype (Figs 4A, S4A and S4B). These cells’ length
defect is not solely due to their higher frequency of ectopic pole formation, as even cells without
ectopic poles are noticeably shorter than isogenic wildtype (S4A Fig). Balanced PonA1 catalytic
activity, however, is required for normal cell length. Whereas TG seems to play a large role in
modulating cell length, PonA1’s TP activity is also required for normal cell length (Fig 2). This
supports the model wherein efficient PG synthesis occurs when one enzyme is catalytically
capable of both synthesizing and crosslinking nascent glycan strands[3]. The linking of
PonA1’s activities provides tight control over cell length and the protection of cell integrity and
growth.
We found that PonA1-specific PG crosslinking is not required in mycobacteria, although it
does promote normal cell length. This suggests that other factors either can compensate for
lack of PonA1 crosslinking when absent or that PonA1 normally functions in the elongation
complex with another crosslinking enzyme[2], as is true for bifunctional PBPs in other bacte-
rial species[3,20]. Because mycobacterial peptidoglycan is estimated to contain predominantly
3–3 crosslinks[36,37] formed by L,D-transpeptidases, these ‘non-classical’ 3–3 crosslinking
enzymes may be active in the elongation complex under wildtype conditions. Indeed, deletion
of LdtB inMtb results in shorter cells[38].
Linear cell growth
We found that PonA1 catalytic activity is required for normal cell length and that PonA1 is an
early acting factor that promotes extension of the cell pole. Overproduced PonA1-RFP localizes
to the cell pole when the cell is still rod-shaped (S5 Fig). These cells then generate an ectopic
pole, which is also marked by PonA1-RFP. We also see the formation of ectopic poles when
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PonA1-FLAG is overproduced (Figs 4 and S4), suggesting that this observation is not an arti-
fact of the fusion partner. Combined with the fact that enzymatically inactive PonA1 induces
ectopic pole formation, these data suggest that PonA1 is important for nucleating elongation
complexes, and that PonA1 is a major factor that promotes pole elongation in mycobacteria.
Because overproduction of enzymatically inactive PonA1 still results in ectopic pole formation,
it is clear that other factors are involved in physically synthesizing new cell wall at these foci.
This could be endogenous PonA1, but other factors are also likely involved in elongation. Iden-
tification of PonA1’s interacting partners would illuminate the composition of the elongation
complex in mycobacteria and provide further understanding of how cell length and cell shape
maintenance are controlled. For example, PonA1 and DivIVA might interact, even transiently,
in the elongation complex. DivIVA is required for the rod-shape of mycobacteria [24] but has
no enzymatic activity. It must coordinate cell growth with the enzymes that synthesize new cell
wall [24]. PonA1, as a key factor that promotes cell elongation, may be one such factor that
DivIVA helps position or facilitate its activity at the pole.
Fig 7. A model for how PonA1 promotes cell elongation in mycobacteria. (A)We propose a model wherein PonA1 localizes early to the growth tip and
promotes pole elongation through PG synthesis. PonA1may recruit other factors to form the elongation complex or they are recruited independently of
PonA1 (factors not shown). Together with these factors, polar elongation proceeds (orange cells). PonA1 furthers cell elongation through its synthesis of PG.
PonA1’s synthesis of glycan strands (colored subunits, panels 1–3) and its crosslinking of those glycan strands (black lines, panels 2–3) promote normal cell
length. These catalytic activities are potentially modulated through PonA1’s phosphorylation (arrow), which acts to regulate the rate of cell elongation. (B)
Excess PonA1 stimulates ectopic cell elongation (orange cells). The frequency of ectopic pole formation increases with imbalanced PG crosslinking and may
result from changes in local peptidoglycan architecture (panels 1–2, factors removed from panel 2 for clarity). These architectural changes may act like a sink
that ‘recruits’ additional protein-interactors of PonA1 or additional elongation complex components to spur cell elongation at ectopic sites (panel 3, dark gray
factors).
doi:10.1371/journal.ppat.1005010.g007
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Even at hyper-physiological levels, PonA1 is properly recruited to the cell pole, as
PonA1-RFP localizes at the pole before it degenerates into ectopic poles (S5 Fig). Furthermore,
ectopic poles are not produced along the cell body. This suggests that the machinery that
recruits PonA1 to the cell pole is not saturated even at increased levels of PonA1 nor is
PonA1’s recruitment mechanism rate-limiting for elongation under physiological levels of
PonA1. Additionally, the ectopic growth pole normally forms at one cell pole, although occa-
sional cells with both cell ends sporting ectopic growth poles have been observed; however,
these cells tend to have multiple septa (S4C Fig, white arrows). These data support a model of
mycobacterial elongation where the cell poles are asymmetrically active, at least for a time
[2,23,30].
Interestingly, the frequency of ectopic poles correlates with specific imbalanced PonA1
activity. The development of ectopic poles was highest with a PonA1 isoform that can crosslink
PG but cannot polymerize glycan strands. The retention of transpeptidase activity in these
mutants might lead to abnormal numbers of PG crosslinks. These data suggest that imbalanced
crosslinking might contort local PG architecture, which may change the curvature of the mem-
brane enough to misdirect elongation complexes to those foci (Fig 7B). Alternatively, PonA1
may nucleate elongation complexes at these contorted foci to then extend a functional growth
pole. Although these ectopic poles elongate over time, they eventually block cell growth. These
data suggest that PonA1’s coordination of polar growth must be tightly regulated to maintain
linearity of the bacterial cell. This may be accomplished through proper protein-protein inter-
actions and regulation of PonA1 activity.
Phosphorylation regulates elongation rate
We found that cell growth is regulated through PonA1’s phosphorylation. Phosphorylation of
PBPs is unusual, and only mycobacteria have so far been reported to phosphorylate their PBPs
[6], suggesting that phosphorylation could regulate the activity of these proteins in mycobacte-
ria. We found that the absence of PonA1’s phosphorylation increased the rate of single cell
elongation (Fig 5), suggesting that PonA1’s phosphorylation normally dampens cell elongation
in bothMsm andMtb. Cells of both species that harbor PonA1 alleles that cannot be phosphor-
ylated (Msm T50A andMtb T34A) are longer, suggesting that phosphorylation negatively reg-
ulates cell elongation (Fig 5). PonA1’s phosphorylation by PknB is consistent with PknB’s
phosphorylation of other members of the PG biosynthetic pathway[39,40]. In fact, PknB regu-
lates PG synthesis at each key point of the pathway: precursor synthesis (GlmU)[40], export
(MviN)[39] and polymerization (PonA1). Interestingly, PknB’s phosphorylation of these three
distinct factors is inhibitory, providing consistent regulation of PG biogenesis at multiple steps.
It would be of interest to determine if PonA1 phosphorylation correlates with stages of the cell
cycle; PonA1 may be phosphorylated as the cells begin the switch from elongation to septation,
where cells need to slow down elongation. Alternatively, PonA1’s phosphorylation status may
cycle with rounds of peptidoglycan synthesis during growth. Further work is required to test
these models in addition to determining if PonA1’s phosphorylation impactsMtb fitness dur-
ing growth during infection.
How PonA1’s phosphorylation specifically regulates cell elongation is unknown, although
our data suggest that it could act to regulate TG activity. In the absence of PonA1 phosphoryla-
tion, TG functionality could be hyperactive. This could lead to increased cell length observed
with T50A cells (Fig 5) and correlates with the shortness ofMtb cells expressing TG- (Fig 1) or
overexpressing TG-Msm cells (Figs 4 and S4). Additionally, when the T50A mutation is com-
bined with TP-,Msm cells exhibit substantial defects in division (Fig 5), which could be a result
of hyper-active glycan chain synthesis without corresponding crosslinking by PonA1’s cis-TP
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domain, altering the normal cellular response to PG synthesis. Differences in antibiotic suscep-
tibility correlate between PonA1’s phosphorylation and enzymatic activity as well. InMtb,
PonA1T34D and PonA1TG- cells exhibit the same rifampicin tolerance (S10A Fig), whereas
T34A and TP- have the same teicoplanin profile (Fig 6). In sum, these data suggest a model
wherein PonA1’s phosphorylation regulates its TG activity (Fig 7A). How this could be
achieved remains unclear, although it is possible that conformational changes occur upon
phosphorylation. Alternatively, PonA1 phosphorylation may impact the stability of the elonga-
tion complex or of PonA1’s retention in the elongation complex, which could underlie the
changes in cell length observed when cells express phosphorylation mutants. In any case, this is
an unusual example of cytoplasmic regulation of periplasmic protein activity, though, given
the number of phosphorylated proteins found in mycobacteria, this might be a common theme
in these organisms.
Altering PonA1 activity changes antibiotic susceptibility
Changes to PonA1 regulatory or enzymatic activity are required for robust growth during anti-
biotic treatment, suggesting that PonA1 mediates tolerance to drugs that target penicillin bind-
ing proteins or PG synthesis. We found markedly enhanced susceptibility ofMtb andMsm
TP- cells to teicoplanin. Enhanced sensitivity of PonA1 TP- cells may reflect an increased cellu-
lar toxicity from imbalanced peptidoglycan synthesis. Recent work suggested that beta-lactams
are particularly effective because they not only target TP domains of penicillin binding proteins
but they also block crosslinking of nascent glycan strands, leading to an accumulation of non-
crosslinked or improperly crosslinked strands that are then degraded, causing a futile cycle of
synthesis and degradation that consumes resources[41]. Teicoplanin treated PonA1 TP- cells
may experience this cellular toxicity. Because the TP- allele is likely still capable of transglyco-
sylation, it can synthesize nascent glycan strands that will then be blocked from crosslinking
when cells are treated with a crosslinking inhibitor. This could lead to an accumulation of
uncrosslinked glycan strands and induce cellular toxicity, resulting in the increased teicoplanin
sensitivity these cells exhibit. Because the T34A allele demonstrates a similar shifted MIC, it
suggests that glycan strand synthesis is also altered in this mutant. Loss of phosphorylation
may lead to enhanced TG activity, with a consequent imbalance of crosslinking of the new gly-
can chains when cells are treated with teicoplanin. Furthermore, the endogenous mycobacterial
beta-lactamase is ineffective with drugs like teicoplanin, increasing their potential usefulness.
These data suggest that transpeptidation inhibitors, such as teicoplanin, could be a fruitful ave-
nue for TB drug development.
Materials and Methods
Bacterial strains and culture conditions
M. smegmatismc2155 was cultured in Middlebrook 7H9 salts (Becto-Dickinson) supplemented
with ADC (5 g/L albumin, 2 g/L dextrose, 3 g/L catalase), 0.25% glycerol, and 0.05% Tween-80
or plated on LB agar.M. tuberculosisH37Rv was cultured in Middlebrook 7H9 salts supple-
mented with OADC (oleic acid, albumin, dextrose, catalase [BD Biosciences, Franklin Lakes,
NJ]), 0.25% glycerol, and 0.05% Tween-80 or plated on 7H10 agar. Selection was performed at
50 μg/ml hygromycin, 25 μg/ml kanamycin, 20 μg/ml zeocin or 20 μg/ml nourseothricin for
both liquid and solid media. E. coli XL-1 Blue (Stratagene, Santa Clara, CA) or TOP10 (Invitro-
gen, Carlsbad, CA) were used for cloning and were cultured in LB broth or agar. Selection for
E. coli occurred at 100 μg/ml hygromycin, 50 μg/ml kanamycin, 20 μg/ml zeocin or 50 μg/ml
nourseothricin for both liquid and solid media. All strains were grown at 37°C. The generation
of single copy PonA1 mutant strains is described further below. To generate multicopy PonA1
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strains, alleles of ponA1 were subcloned into an anhydrotetracycline inducible pMS2 derivative
plasmid[42]. These plasmids were transformed into anM. smegmatismc2155 strain with the
pMC1s plasmid[42], encoding the tetR repressor, integrated at the L5 phage integration site.
Recombinant DNA constructs
M. smegmatis PonA1 (MSMEG_6900) andM. tuberculosis PonA1 (Rv0050) catalytic mutants
were generated using site directed mutagenesis and PCR stitching with the primers in S1 Table.
M. smegmatis PonA1 truncation mutants were generated with primers listed in S1 Table. The
double T50A,TP- Msm PonA1 construct was generated via PCR stitching using the appropri-
ate primers in S1 Table. For all Mtb PonA1 constructs, the -426 start site was used. All con-
structs used in this study were cloned under the strong promoter pUV15 modified to contain
TetR operator sites[42] (although no TetR is encoded in the cells’ genomes so expression of
ponA1 is constitutive). All PCR reactions were performed with KOD Xtreme Hot Start DNA
polymerase (EMDMillipore, Billerica, MA). AllM. smegmatis andM. tuberculosis PonA1 con-
structs listed above were cloned as translational fusions with either the FLAG epitope or mono-
meric red fluorescent protein (RFP). The FLAG epitope and RFP do not obstruct PonA1
function, as both tags recombineered onto the C-terminus of ponA1 on the chromosome com-
plementMsm survival.
Deletion of ponA1 inM. tuberculosis
A ponA1 (Rv0050) knockout construct was generated by PCR and subcloning. Because ponA1
exists in an operon, the 5’ and 3’ 25 nucleotides of ponA1 were preserved in the knockout con-
struct. The 500 nucleotides upstream of ponA1 were PCR amplified with a 3’ NdeI restriction
endonuclease site. The 500 nucleotides downstream of ponA1 were PCR amplified with a 5’
PvuI restriction endonuclease site. A hygromycin resistance cassette flanked by loxP sites was
amplified with a 5’ NdeI site and a 3’ PvuI site. These three fragments were subcloned by digest-
ing with NdeI and/or PvuI. The final ligated product was PCR amplified and used to replace
ponA1 in theMtbH37Rv genome via recombineering[43]. Cells were plated on 7H10 plates
with 50 μg/ml hygromycin. After incubation at 37°C for three weeks, colonies were inoculated
into 2 ml of selective 7H9. Cell lysates were generated and screened by PCR for correct recom-
binants. One out of 11 colonies was positive for recombination; loss of ponA1 from the genome
was verified by PCR and whole genome sequencing.
Ethics statement
The Institutional Animal Care and Use Committee of Harvard University approved and moni-
tored all protocols, personnel, and animal use. The animal facilities are AAALAC accredited,
and work was performed under the NIH Office of Laboratory Animal Welfare (OLAW) permit
number A-3431-01.
Mouse infections
Six week old wildtype female C57Bl6 mice (Jackson Laboratories, Bar Harbor, ME) were aero-
sol infected with low doses ofM. tuberculosisH37Rv wildtype, H37Rv ΔponA1::Hyg, H37Rv
ΔponA1::Hyg L5::ponA1wt, and H37Rv ΔponA1::Hyg L5::ponA1TG-. Strains were confirmed as
PDIM positive by mass spectrometry prior to infection using established protocols[44]. Fifteen
mice were infected per strain, and five mice were sacrificed at 1 day, 15 days, and 42 days post
infection, respectively. To minimize suffering, animals were first put to sleep with isoflurane
before sacrifice. Lungs and spleens were homogenized and serially diluted on selective 7H10
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plates (for the genetically modified strains) or 7H10 plates lacking antibiotics (for H37Rv wild-
type) for CFU enumeration.
Allelic exchange inM. smegmatis
Amarked copy of PonA1 was first integrated in the chromosome at the L5 phage integration
site. The endogenous locus of PonA1 was then replaced with a different antibiotic cassette via
recombineering. This dual marked strain was then transformed with an L5-integrating vector
that is marked with a third antibiotic cassette. This second integration event replaces the origi-
nal integrated allele, and selection for the third antibiotic recovers cells with the desired allele
(Fig 1A). Exchange at the L5 site is imperfect and to confirm desired transformants, cells are
patched onto plates containing the first L5 integrant marker or the second L5 integrant marker.
Cells that are mono-resistant to the second L5 integrant antibiotic are counted as correct trans-
formants; frequencies of correct transformation are calculated by comparison to wildtype
ponA1 control transformations.
Bocillin labeling
FLAG-tagged isoforms ofM. smegmatis PonA1 were produced in TOP10 E. coli. Untrans-
formed TOP10 cells were used as a negative control. Cells were grown overnight in LB and
back-diluted 1:100 into 10ml of LB. Once cells reached 0.5 OD600, they were pelleted. Cell pel-
lets were washed once in 1ml of 1x PBS, resuspended in 1ml of 1x PBS, and sonicated twice for
30 seconds each. Bocillin-FL (Life Technologies) was added to the cell solutions at a final con-
centration of 15 μg/ml and allowed to label protein for 30 minutes at room temperature in the
dark. The labeled cell solutions were then pelleted at 100,000 g for 20 minutes to concentrate
membrane proteins. The pellets were resuspended in 100 μl of sample buffer containing βME.
Proteins were resolved by SDS-PAGE using a 4–15% Tris-Glycine gel. Bocillin-labeled proteins
were visualized by imaging with a Typhoon 9400 Variable Mode Imager (GE Healthcare).
Timelapse microscopy and data analysis
For the data in Figs 5 and S8, vegetatively growingM. smegmatis cells were washed twice in 1X
PBS with 0.1% Tween 20, stained with 50 μg/ml Alexa488 (Invitrogen), and filtered twice
through a 10 μm filter to obtain single cells. Cells were inserted into custom microfluidic
devices (see Reference [23]) and imaged at 37°C with constant flow of selective 7H9. Cells were
imaged with a DeltaVision PersonalDV microscope using the 60x objective (Plan APO
NA1.42) every 10 minutes for a minimum of 18 hours. Images were captured with a CoolSnap
HQ2 camera (Photometric). Cell elongation and division events were annotated using ImageJ
(National Institutes of Health) with the ObjectJ plugin (Norbert Vischer and Stelian Nastase,
University of Amsterdam, http://simon.bio.uva.nl/objectj/index.html). Cell elongation was
measured as new unstained cell wall material; cell division was defined as the first frame when
physical invagination of the cell wall was visible. A custom Python script was used to analyze
the annotations.
For the data in S4 Fig,M. smegmatis cells were imaged using a CellASIC microfluidic system
(EMDMillipore, Billerica, MA). Vegetatively growing cells were cultured for four hours ± 100
ng/mL anhydrotetracycline (aTc) inducer to overexpress PonA1TG—RFP prior to growth in the
CellASIC chambers. Cells were imaged every 15 minutes for 17 hours with constant flow of
selective 7H9 ± 100 ng/mL aTc. Images were captured by a Nikon Eclipse TI microscope using
the 60x objective, which is maintained at 37°C with an objective heater. Images were captured
with a CoolSNAP SQ2 camera. The image montage in S4 Fig was compiled with FIJI[44].
PonA1 Governs Mycobacterial Polar Growth
PLOS Pathogens | DOI:10.1371/journal.ppat.1005010 June 26, 2015 20 / 28
Light microscopy and image analysis
For imaging, cells were washed once in 1x PBS and resuspended in 1X PBS ± 2.5 μg/ml FM4-
64Fx (Invitrogen) to visualize the plasma membrane. After resuspension, cells were incubated
in the dark for 10 minutes prior to imaging. ForM. tuberculosis, cells were first fixed overnight
in 1% formalin in the biosafety level 3 facility before removal and consequent imaging. Cells
were imaged on a Nikon TE-200E microscope using the 100x (NA1.40) objective. Images were
captured with an Orca-II ER cooled CCD camera (Hamamatsu, Japan). Exposure and image
acquisition were controlled with Metamorph Software (Molecular Devices). Final images were
prepared in Adobe Photoshop CS3. To quantitate cell length, the fluorescent images of cells
stained with FM4-64Fx were used. Cell length was calculated using ImageJ software (National
Institutes of Health) and converted to microns using the appropriate pixel to micron conver-
sion. Length was measured from cell pole to the opposite cell pole or from cell pole to septum,
if present. Cell synchronization is not yet possible for mycobacteria; hence, cell lengths were
measured for unsynchronized populations. To quantitate the frequency of multi-poled cells,
cells were both imaged and scored blind to eliminate potential bias. The figure shows data
from five combined experiments. 2652 cells were imaged and counted for PonA1wt, 2910
cells for PonA1TG- cells, 2054 for PonA1TP- cells, and 2379 for PonA1TG-TP- cells. The control
represents data collected from uninduced cells. Overexpression of PonA1 was induced with
100 ng/mL aTc.
In vitro kinase assays and detection of PonA1’s phosphorylation site
N-terminally his-MBP-tagged kinase domains of the nine canonical serine-threonine protein
kinases fromMtb were expressed and purified from E. coli using a nickel column and then an
S75 size exclusion column, in kinase buffer (50 mM Tris pH7.5, 150 mMNaCl, 20% glycerol).
His-MBP-PonA1 (cytoplasmic domain) was expressed and purified from E. coli using Ni-NTA
beads (Novagen) according to the protocol recommended by the manufacturer. Protein levels
were measured by A280, and kinase reactions were started by mixing 1 μg of kinase, 10 μg of
his-MBP-PonA1(cyto), 1mMMnCl2 and 1mM ATP. Reactions were incubated at room tem-
perature for 1 hour and stopped by addition of Laemmli buffer. Samples were heated, separated
by SDS-PAGE, and detected by western blot using α-phospho-threonine antibody (Cell Signal-
ing Technology). Kinase reactions for mass spectrometry were performed the same way, using
only his-MBP-PknB and his-MBP-PonA1(cyto). The his-MBP-PonA1 protein band was cut
out of the polyacrylamide gel and in-gel trypsin digested. Samples were analyzed by liquid
chromatography (LC)/MS/MS with an Agilent 6520 Accurate-Mass Quadrupole Time-of-
Flight instrument. Peptides were separated on a POROSHELL 300SB-C18 (2.1 × 75 mm, 5 μm)
at a 0.5 mL/min flow rate, by using a linear gradient of increasing acetonitrile in water. Spec-
trumMill software (Agilent) was used to identify peptides.
Antibiotic treatment and determination of bacterial cell fitness
The antibacterial effects of teicoplanin (Sigma Aldrich, St. Louis, MO) and moenomycin A
(Sigma Aldrich, St. Louis, MO) were determined by culturing exponentially growingM. tuber-
culosis orM. smegmatis cells in complete 7H9 in non-treated 96 well plates (Genesee Scientific,
San Diego, CA) in the presence of serially diluted drug, in duplicate. Plates also contained
duplicate untreated wells as controls.M. tuberculosis was grown to OD600 of 0.5 before
culturing ± drug at a calculated starting OD600 of 0.006 for six days at 37°C with shaking.M.
smegmatis was grown to OD600 of 0.5 before culturing ± drug at a calculated starting OD600 of
0.05 for 16 hours at 37°C with shaking. Bacterial growth was evaluated by adding 0.002% resa-
zurin (Alamar Blue, Sigma Aldrich, St. Louis, MO) to each well.M. tuberculosis plates were
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incubated with resazurin for 18–24 hours.M. smegmatis plates were incubated with resazurin
for 3–5 hours. Wells were scored as blue or purple indicating metabolically inactive cells and
pink as metabolically active cells. The inhibitory effects of meropenem (Sigma Aldrich,
St. Louis, MO) were determined by growingM. smegmatis to an OD600 of 0.5 before
culturing ± drug at a calculated starting OD600 of 0.1. Cells were grown in complete 7H9 in 96
well honeycomb plates (Growth Curves USA, Piscataway, NJ) ± drug, in triplicate, at 37°C
with shaking in a Bioscreen growth curve machine (Growth Curves USA, Piscataway, NJ).
Optical density was measured by absorbance at 600nm every 30 minutes for 48 hours. The
inhibitory effects of rifampicin (Sigma Aldrich, St. Louis, MO) were determined by growingM.
tuberculosis to an OD600 of 0.5 before culturing ± drug at a calculated starting OD600 of 0.1.
Cells were grown in complete 7H9 in 24 well untreated plates ± drug, in triplicate, at 37°C with
shaking. Optical density was measured after six days, and growth was normalized to untreated
control wells.
Optical density measurements
Population growth curves forM. smegmatis strains were performed in 96 well honeycomb
plates (Growth Curves USA, Piscataway, NJ), in triplicate, at 37°C with shaking in a Bioscreen
growth curve machine (Growth Curves USA, Piscataway, NJ). Cells were grown to an OD600 of
0.5 before beginning the growth curve at a calculated starting OD600 of 0.1. Cells were grown in
complete 7H9 with the appropriate antibiotic selection. Optical density was measured by
absorbance at 600nm every 30 minutes for 48 hours. Error bars are often too small to see. Pop-
ulation growth curves forM. tuberculosis strains were performed in 30 ml inkwells (Corning
Life Sciences, Corning, NY), in triplicate, at 37°C with shaking. Cells were grown to an OD600
of 0.5 before beginning the growth curve at a calculated starting OD600 of 0.1. Cells were grown
in complete 7H9 with the appropriate antibiotic selection. Optical density was measured daily
by absorbance at 600nm.
Immunoblotting
Cells were pelleted, washed once in 1X PBS, and lysed by bead-beating. 6X Laemmli buffer was
added to the whole cell lysate and then boiled for 10 minutes. Proteins were separated on a 12–
14% Tris-Glycine SDS PAGE gels (BioRad, Hercules, CA), transferred to PVDF membrane
(Pall Corp, Pensacola, FL), incubated with anti-FLAG antibodies (Sigma Aldrich, St. Louis,
MO) at 1:15,000 dilution, washed thrice in 1X PBST, and incubated with a 1:1000 dilution of a
secondary antibody conjugated to HRP (Pierce, Rockford, IL). Membranes were incubated
with SuperSignal chemiluminescent reagent (Thermo Fisher Scientific, Rockford, IL) for 5
minutes in the dark and imaged on a FluorChem8900 (AlphaInnotech, Santa Clara, CA).
Data representation and statistical analysis
Prism 6.0 software (GraphPad Software, La Jolla, CA) was used to graph and analyze numerical
data. Statistical tests in the Prism software were used to calculate significance of measurements
as described in the figure legends. The doubling times in S2 Fig and S9 Fig were generated by
fitting an exponential growth function (in Prism) to all datapoints between 5 and 13 hours of
OD600 measurements.
Supporting Information
S1 Fig. Changes to PonA1 function modestly impactsMtbmorphology. (A) Cells that no
longer express PonA1 or that express PonA1 catalytic or regulatory mutants exhibit no gross
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morphological changes. Scale bar, 2 μm. (B) Population doubling is not severely impacted by
loss of PonA1 when cells are grown in standard laboratory conditions. (C) Expression of cata-
lytic mutants of PonA1 does not significantly impact population doubling rates, suggesting
that the defect observed during infection is not due to changes in growth rate. (D) Similarly,
changes to PonA1’s regulatory activity do not significantly change population doubling rates.
(TIF)
S2 Fig. Normal cell growth requires a fully functional PonA1. (A) A panel of PonA1 mutants
was constructed to investigate the cellular role of PonA1. Catalytic mutations in the TG or TP
domain replace the active site serine with an alanine to abolish enzymatic activity (red X). The
phosphorylation mutations either remove the phosphorylation site (yellow bar) by replacing
the phosphorylated threonine with an alanine (lack of yellow bar) or attempt to mimic the
phosphorylation with a threonine to aspartic acid mutation (dark red bar). The truncation
mutations were deletion of the majority of the cytoplasmic tail (Msm PonA195-827) or of the TP
domain (Msm PonA11-360). (B) FLAG immunoblotting demonstrates that E. coli cells express
Msm PonA1-FLAG. Lane 1, negative control (wildtype E. coli); lane 2,Msm PonA1wt-FLAG,
lane 3,Msm PonA1TP—FLAG, lane 4,Msm PonA1TG—FLAG, lane 5,Msm PonA1TG-TP
—FLAG. (C) Expression of PonA1TP—FLAG complements bacterial growth, although popula-
tion doubling rates are slightly dampened. (D) During exponential growth, the TP- cells have
an average doubling time of 4.21 hours, whereas isogenic wildtype doubles on average every
3.40 hours (p-value< 0.0001 by the unpaired two-tailed t-test). (E) The PonA1TP—FLAG iso-
form is stable, suggesting the phenotype of short cell length is due to lack of PonA1’s PG cross-
linking. (F) Expression of an allele that encodes only PonA1’s TG domain (PonA11-360-FLAG)
complements bacterial survival, although it dampens population doubling rates. (G) During
exponential growth, PonA11-360 cells double on average every 4.23 hours, whereas isogenic
wildtype doubled every 3.45 hours in this experiment (p-value< 0.0001 by the unpaired two-
tailed t-test). (H) The PonA11-360-FLAG protein is stable, suggesting the cell shape changes
observed are due to changes in PonA1 function because of the truncated allele and not due to
an unstable protein isoform.
(TIF)
S3 Fig. Mass spectrometric quantitation of pthiocerol dimycocerosate (PDIM) for strains
used for mouse infections. Total cell wall lipids fromM. tuberculosis in mid-log phase growth
were extracted with chloroform:methanol and quantitated using established liquid chromatog-
raphy-mass spectrometry protocols[45]. Individual PDIM A and PDIM B species were identi-
fied based on characteristic retention times and highly accurate mass matching (NH4
+ adducts).
(TIF)
S4 Fig. Overproduction of PonA1 mutants changesMsm cell shape. (A) Cells that overex-
press different catalytic variants of PonA1 exhibit cell shape changes, including ectopic polar
growth, bulging poles, and altered cell length. Cells were imaged six hours of induction. Scale
bar, 2 μm. (B) Quantitation of cell length of cells in (A). A TG- allele of PonA1 negatively
impacts cell length more than other catalytic variants, perhaps because these cells also produce
the highest frequency of ectopic poles. Cells that do not exhibit an ectopic pole are shorter than
wildtype, however, which may suggest a role for balanced PG synthesis in productive activity
of the elongation complex (control: 237 cells; wildtype: 226 cells; TG-: 244 cells; TP-: 163 cells;
TG-TP-: 234 cells; representative data. Significance was assessed by the Kolmogorov-Smirnov
test. PonA1wt compared to PonA1TG- approximate p-value< 0.0001; PonA1wt compared to
PonA1TP- approximate p-value< 0.0001; PonA1wt compared to PonA1TG-TP- approximate p-
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value< 0.0001). (C) Overexpression of PonA1 leads to ectopic poles usually at one pole; rare
cells are observed with both poles having formed ectopic poles. However, these cells usually
exhibit multiple septa (white arrows), indicating these cells are not truly uni-cellular and are
not an accurate reflection of ‘symmetrically’ active growth poles. (D) Endogenous PonA1
tagged with RFP on the chromosome localizes to the cell pole and mid-cell inM. smegmatis.
(TIF)
S5 Fig. PonA1 is an early polar localizing factor that drives polar growth. (A)Msm cells that
encode an overexpression vector for the TG- allele of PonA1-RFP were grown ± inducer to
overproduce PonA1TG—RFP for four hours. The cells were then imaged for 17 hours ± inducer
in the CellASIC microfluidic system to visualize cell growth. Cells that overexpress PonA1TG
—RFP exhibit slow population growth as previously observed. PonA1 localizes to the pole prior
to budding of the ectopic pole (follow cell with white arrow), suggesting that PonA1 is an early
localizing factor at the growth tip and drives growth of the pole or ectopic pole upon PonA1
overproduction. Scale bar, 2 μm. (B) PonA1TG—RFP cells grown without inducer exhibit nor-
mal morphology in the CellASIC microfluidic system and grow robustly. Scale bar, 2 μm.
(TIF)
S6 Fig. Mycobacterial PonA1 encodes a phosphorylated cytoplasmic domain. (A)We used
an H37Rv PonA1 (rv0050) construct with a start site 426 nucleotides upstream of the anno-
tated start. This start site generates a protein with a predicted transmembrane pass, as expected
for PBPs, and captures the translational start site. Alignment of the start site forMsm PonA1
(MSMEG_6900) with theMtb genes shifts the start site by 126 nucleotides upstream. (B) The
-426Mtb PonA1 and -126Msm PonA1 protein align well with the CDC1551 sequence for
PonA (proteins were aligned with ClustalO on the EBI server). These proteins contain a phos-
phorylated threonine (H37Rv PonA1 T34A;Msm PonA1 T50A, yellow box). (C) Truncation
of PonA1’s cytoplasmic tail or alteration of its phosphorylation site do not alter protein stabil-
ity, suggesting the observed phenotypes are not due to aberrant protein production or folding.
(TIF)
S7 Fig.M. tuberculosis PonA1 complementsM. smegmatis survival. (A)Msm cells that
expressMtb -426 PonA1 show no morphological differences. Scale bar, 2 μm. (B) TheMsm
cells that only expressMtb -426 PonA1 also double at rates identical to isogenic wildtype, sug-
gesting that -426 PonA1 fully complements growth ofMsm that lacks endogenous PonA1. (C)
TheMtb PonA1 allele is produced at similar levels toMsm PonA1 (the nonspecific band dem-
onstrates lane 2 has less protein loaded). (D)Mass spectrometric analysis confirms that PknB
phosphorylatesMtbMBP-PonA1cyto (with the -426 start site) in vitro.
(TIF)
S8 Fig. PonA1 phosphorylation regulates single cell elongation rates. (A)Msm cells that
express phosphorylation mutants (T50A and T50D) or a truncation of the cytoplasmic tail of
PonA1 (Δcyto) exhibit similar population doubling rates to isogenic wildtype or wildtypeMsm.
(B) To investigate the impact of PonA1’s phosphorylation on cell elongation and division, cells
were stained with a green fluorescent dye that binds to the cell surface. After staining, single
cells were imaged in custom microfluidic devices, and new cell wall elongation and division
events were measured. (C) The increase in single cell elongation rate of cells that express
PonA1T50A correlates with an increased length of single cells at division, as expected. (PonA1wt
compared with PonA1T50A approximate p-value< 0.0001 by the Kolmogorov-Smirnov test.
PonA1wt compared with PonA1Δcyto approximate p-value< 0.0001 by the Kolmogorov-Smir-
nov test). (D) Expression of T50A or Δcyto PonA1 do not impact single cell generation times.
This suggests that the observed increased cell length is due to faster single cell elongation rates
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alone and is not impacted by altered septation timing. Significance was assessed by the Kolmo-
gorov-Smirnov test, and neither mutant population was statistically different than PonA1wt.
(E) Cell elongation still occurs predominantly from the old pole in the absence of PonA1’s
phosphorylation or cytoplasmic tail. (PonA1wt compared with PonA1T50A approximate p-
value< 0.0001 by the Kolmogorov-Smirnov test. PonA1wt compared with PonA1Δcyto approxi-
mate p-value< 0.0001 by the Kolmogorov-Smirnov test). (F) The new pole exhibits mild
increased elongation in cells that express T50A or Δcyto PonA1 compared to wildtype.
(PonA1wt compared with PonA1T50A approximate p-value = 0.0036 by the Kolmogorov-
Smirnov test. PonA1wt compared with PonA1Δcyto approximate p-value = 0.0261 by the
Kolmogorov-Smirnov test). Together with (E), these data suggest that loss of PonA1’s phos-
phorylation does not impact subcellular distribution of elongation complexes or PonA1’s local-
ization within the elongation complex itself, since the majority of cell elongation still occurs at
the old pole.
(TIF)
S9 Fig. Inactivating PonA1’s phosphorylation site and TP active site together impacts cell
growth. (A) Cells that express a T50A,TP- allele of PonA1 exhibit slower population doubling
time as compared to the single point mutants or isogenic wildtype, suggesting that PonA1’s
phosphorylation may regulate TG activity to promote normal cell elongation and division. (B)
T50A cells double on average every 3.52 hours, TP- cells double every 4.21 hours (p-
value< 0.0001 by the unpaired t-test compared to isogenic wildtype), and T50A,TP- cells dou-
ble every 4.92 hours (p-value< 0.0001 by the unpaired t-test compared to isogenic wildtype; p-
value = 0.0008 compared to TP- cells; p-value< 0.0001 by the unpaired t-test compared to
T50A cells), whereas isogenic wildtype doubles every 3.40 hours. (C) The T50A,TP- allele is
translated into a stable protein.
(TIF)
S10 Fig. Antibiotic tolerance shifts when PonA1’s activity changes. (A) PonA1 single nucle-
otide polymorphisms identified in clinical isolates have previously been shown to change the
tolerance ofM. tuberculosis to rifampicin, a frontline tuberculosis therapy. We measured the
impact of PonA1 catalytic and regulatory mutants on cell fitness during rifampicin treatment,
and found that PonA1TG- and PonA1T34D mutants have 5- and 4-fold increased tolerance to
rifampicin compared to isogenic wildtype. Other catalytic (TP-, TG-TP-) or regulatory (T34A)
mutations do not alter rifampicin susceptibility. These data suggest that PonA1’s phosphoryla-
tion may regulate PonA1’s TG activity and that alterations to PonA1 function impact rifampi-
cin tolerance. (Statistical significance was assessed by one-way analysis of variance with
Bonferroni’s multiple comparison test, and multiplicity adjusted p-values are reported.
PonA1wt compared to PonA1TG- p-value< 0.0001; PonA1wt compared to PonA1TG-TP- p-
value = 0.0295; PonA1wt compared to PonA1T34D p-value< 0.0001). (B) Changes to PonA1
activity also influence cell fitness in the presence of TP domain inhibitors, including those that
target both D,D- and L,D-transpeptidases (meropenem). The expression of T50A PonA1 impacts
M. smegmatis cell fitness during meropenem treatment, corroborating the importance of nor-
mal PonA1 regulatory activity in the maintenance of cell fitness during antibiotic pressure. (C)
The TG inhibitor moenomycin exhibits modest efficacy againstMsm andMtb.
(TIF)
S11 Fig. Normal PonA1 activity is required for cell fitness during stress. (A) Cells that lack
PonA1’s TP activity are less fit during incubation with SDS as compared to isogenic wildtype
cells. This suggests that loss of PonA1’s PG crosslinking impinges on cell wall integrity. (B)
Cells that express a PonA1 T50A allele also exhibit a modest defect in population doubling in
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the presence of SDS, suggesting changes to PonA1’s phosphorylation status also impact cell
wall integrity. (C) Incubating isogenic wildtypeMsm cells in the presence of D-amino acids,
which may be incorporated into the cell wall, shows that PonA1’s PG crosslinking may be
important for properly incorporating these non-canonical amino acids into the cell wall. (D)
Cells that lack PonA1’s TP activity exhibit less robust population growth in the presence of
D-Met. (E) Cells that express a TP- PonA1 exhibit cell shape defects when in deep stationary
phase (cultured for four days). Cells become wider, shorter and rounder than isogenic wildtype,
suggesting that PonA1’s crosslinking is important for PG integrity during stress.
(TIF)
S1 Table. Primers used to generate recombinant DNA constructs.
(XLSX)
S1 Video. PonA1 localizes to the pole before it degenerates into ectopic poles.
(ZIP)
S2 Video. Cells that do not overexpress PonA1 do not form ectopic poles.
(ZIP)
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